Morphologic Examination of Sequential Bone Marrow Biopsies after Nonmyeloablative Stem Cell Transplantation Complements Molecular Studies of Donor Engraftment
Timothy T. Stenzel , Anand S. Lagoo , Cristina Gasparetto , Barbara K. Goodman
Archives of Pathology & Laboratory Medicine 130 ( 10) 1479 -1488
1
2006
Method of including apoptosis/Cell death in leukemia cell using a purine nucleoside analogue
Brice J. Weinberg , David A. Rizzieri , Daphne R. Friedman , George J. Cianciolo
2011
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.
Carlos M. DeCastro , James J. Vredenburgh , Jon P. Gockerman , Valerie K. Ibom
Clinical Cancer Research 9 ( 2) 663 -668
17
2003
Hematopoietic Stem Cell Transplantation at Home
Stefanie Sarantopoulos , Jennifer Frith , Julia A. Messina , Cristina J. Gasparetto
Blood 130 745 -745
1
2017
Preliminary Results of a Phase 1 Study of Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
John F DiPersio , Bob Lowenberg , Fabio Ciceri , Geoffrey L. Uy
Blood 130 637 -637
35
2017
A Phase I Study of FLX925, a Dual FLT3 and CDK4/6 Inhibitor in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Tibor Kovacsovics , Daniel A. Pollyea , Dale L. Bixby , Alexander E. Perl
Blood 130 1343 -1343
4
2017
Results from an Ongoing Phase 1 Study Indicate ACDT-301 (Camidanlumab Tesirine) Is Well-Tolerated in Patients with Relapsed or Refractory CD25-Positive Acute Leukemia
Aaron D Goldberg , Ehab Atallah , David A. Rizzieri , Shui He
Blood 130 2662 -2662
7
2017
Lead-in Dose Optimization to Mitigate Cytokine Release Syndrome in AML and MDS Patients Treated with Flotetuzumab, a CD123 x CD3 Dart® Molecule for T-Cell Redirected Therapy
John F DiPersio , Bob Lowenberg , Fabio Ciceri , Geoffrey L. Uy
Blood 130 3856 -3856
4
2017
Results of a Phase 3 Study of Elderly Patients with Newly Diagnosed AML Treated with Sapacitabine and Decitabine Administered in Alternating Cycles
Tapan Kadia , Farhad Ravandi , Yosr Hicheri , Judy Chiao
Blood 130 891 -891
4
2017
Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell Transplantation
Stefanie Sarantopoulos , Marcel R.M. van den Brink , Marcel R.M. van den Brink , Yvonne M. Mowery
Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy 27 ( 3)
2021
Selective ERBB2 and BCL2 Inhibition Is Synergistic for Mitochondrial-Mediated Apoptosis in MDS and AML Cells.
Stefanie Sarantopoulos , Neil L. Spector , David A. Rizzieri , Angel Y.F. Kam
Molecular Cancer Research 19 ( 5) 886 -899
2021
Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses.
Donna E. Hogge , Jonathan E. Kolitz , Geoffrey L. Uy , Daniel H. Ryan
Blood Advances 5 ( 6) 1719 -1728
2021
Results of Pivotal Phase 2 Trial of SL-401 in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Hagop M. Kantarjian , Naveen Pemmaraju , Kendra L. Sweet , Ivan Bergstein
Blood 130 1298 -1298
13
2017
Results from Ongoing Phase 1/2 Trial of SL-401 As Consolidation Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission with Minimal Residual Disease (MRD)
Hagop M. Kantarjian , Ioannis Mantzaris , Dale L. Bixby , Naveen Pemmaraju
Blood 130 2583 -2583
5
2017
Increased TLR7 Signaling of BCR-Activated B Cells in Chronic Graft-Versus Host Disease (cGVHD)
Stefanie Sarantopoulos , Steven Z. Pavletic , Jonathan C Poe , Mitchell E. Horwitz
Blood 130 75 -75
2017
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
Mary-Elizabeth Percival , Hai-Lin Wang , Mei-Jie Zhang , Wael Saber
Bone Marrow Transplantation 1 -10
2021
A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Olatoyosi Odenike , Ibrahim Aldoss , Gautam Borthakur , Thomas Prebet
Cancer
2021
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.
Stefanie Sarantopoulos , Therese Hennig , Cristina Gasparetto , Mitchell E. Horwitz
Blood Cancer Journal 11 ( 5) 92
2021
Age-Specific Differences in Oncogenic Pathway Dysregulation in Patients With Acute Myeloid Leukemia
Arati V. Rao , Peter J.M. Valk , Klaus H. Metzeler , Chaitanya R. Acharya
Journal of Clinical Oncology 27 ( 33) 5580 -5586
75
2009
Pre-Transplant Hepatic Steatosis (fatty liver) Predicts Chronic Graft-Vs-Host Disease but Does Not Affect Mortality
Ko Ko Ko Maung , Mohammad Chaudhry , Yi Ren , Sin-Ho Jung
Blood 134 5731 -5731
2019